PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia-Reference-Cited by-同舟云学术

PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia

Published:2011-11 Issue:4-5 Volume:82 Page:220-236
ISSN:0301-4681
Container-title:Differentiation
language:en
Short-container-title:Differentiation

Author:

Jiang Ming,Strand Douglas W.,Franco Omar E.,Clark Peter E.,Hayward Simon W.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Developmental Biology,Molecular Biology

Reference218 articles.

1. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site;Adams;J. Biol. Chem.,1997

2. National trends in treatment of type 2 diabetes mellitus, 1994–2007;Alexander;Arch. Intern. Med.,2008

3. Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60mg once daily before sleeping;Araki;Acta Med. Okayama,2004

4. Mouse phenogenomics: the fast track to “Systems metabolism”;Argmann;Cell Metab.,2005

5. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose–response study. The Pioglitazone 001 Study Group;Aronoff;Diabetes Care,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance;The Prostate;2024-01-03

2. Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?;Journal of Urological Surgery;2023-09-01

3. Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats;Biomolecules and Biomedicine;2023-05-19

4. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients;The Prostate;2022-07-12

5. PPARγ2 functions as a tumor suppressor in a translational mouse model of human prostate cancer;Asian Journal of Andrology;2022